SK bioscience will make strategic equity investment into Novavax to respond to the endemic and strengthen strategic partnership. SK bioscience and Novavax also extended their existing license agreement for Novavax’s updated COVID vaccine. Companies to shift focus from contract…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.